Novel Osteoporosis Drug Fares Well in Phase III Trial (CME/CE)

(MedPage Today) -- 18-month NNT of 28 for spine fracture in low-risk women
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news